Works citing this work

2 works

Work: The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

1. Catumaxomab

   James E. Frampton

   Review articleNanoparticle-Based Drug DeliveryDrugs20121 citations

   ABIABI:AkademIndex/openalex/2012.review-article.000001

2. Catumaxomab: First Approval

   Yahiya Y. Syed

   Review articleCancer therapeutics and mechanismsDrugs20250 citations

   ABIABI:AkademIndex/openalex/2025.review-article.000255